We can't find the internet
Attempting to reconnect
Something went wrong!
Hang in there while we get back on track
This item is currently unavailable
The 2025-2030 World Outlook for Myasthenia Gravis Treatments
Price data last checked 128 day(s) ago - refreshing...
One email. No newsletter. No nudges.
Gone for 128 days. Could come back at any time — we're watching for you.
Out of stock 128 days · longest previous gap was 1 days
NEW HERE?
Amazon shows you one price. We show you all of them.
Tosheroon watches Amazon prices so you don't have to. Every product on Amazon has a price history — we make it visible. Set the price you'd actually pay, and we'll email you the second it gets there. No app, no account, one email.
WHAT'S ON THIS PAGE
when this has been cheap or pricey
where the price is heading next
all-time high & low, recent range
name your number, we'll email you
Price History & Forecast
Grey patches = out of stock. Cheaper = lower on the chart. Hover for exact prices.
No Price Data Available
Price history will appear here once data is collected from Amazon.
Price Distribution
No price data available for histogram
Product Specifications
- Format
- paperback
- ASIN
- B0CZ2MX15P
- Category
- Books > Subjects
- Domain
- Amazon UK
- Release Date
- 03 March 2024
- Listed Since
- 02 May 2024
Similar Products You Might Like
The 2025-2030 World Outlook for Myasthenia Gravis Drug Treatments
The 2025-2030 World Outlook for Myasthenia Gravis
The 2025-2030 World Outlook for Myasthenia Gravis Drugs
The 2023-2028 Outlook for Myasthenia Gravis in India
A Look into Myasthenia Gravis
IntechOpen
Ocular Myasthenia Gravis (Experts' Perspectives on Medical Advances)
Springer
Myasthenia Gravis, Part B: Volume 183 (International Review of Neurobiology, Volume 183)
Academic Press
Myasthenia Gravis, Part A: Volume 182 (International Review of Neurobiology, Volume 182)
Academic Press
Myasthenia Gravis and Related Disorders (Current Clinical Neurology)
Humana
Myasthenia Gravis and Related Disorders (Current Clinical Neurology)
Humana
The 2025-2030 World Outlook for Spinal Muscular Atrophy
Myasthenia Gravis and Related Disorders (Current Clinical Neurology)
Humana
The 2016-2021 Outlook for Multiple Sclerosis Therapeutics in the United States
The 2025-2030 World Outlook for Muscle Stimulation Devices
The 2023-2028 World Outlook for Guillain-Barre Syndrome Therapeutics
The 2023-2028 Outlook for Guillain-Barre Syndrome Therapeutics in India
The 2023-2028 Outlook for Anti-Vascular Endothelial Growth Factor Therapy (Anti-VEGF) for Non-Infectious Macular Edema in the United States
The 2025-2030 World Outlook for Amyotrophic Lateral Sclerosis
The 2023-2028 Outlook for Guillain-Barre Syndrome Therapeutics in China
The 2023-2028 Outlook for Game Mouse and Keyboards in the United States
Acquired Neuromuscular Disorders: Pathogenesis, Diagnosis and Treatment
Springer
Treatment of Eye Motility Disorders
IntechOpen
The 2013-2018 Outlook for Lou Gehrig's Disease Drugs in India
Neuromuscular Diseases - How to Recognize and Treat Them
IntechOpen